Most Read News

On a consolidated basis, revenue rose 6.7% YoY to ₹2.40 lakh crore, up from ₹2.25 lakh crore in the corresponding quarter last year.

So far, the firm had invested about $5 million on pre-development work for a 484 MW wind farm in Mannar and Pooneryn and on the development of Sri Lanka’s 220 KV and 400 KV transmission network.

The IIP growth for December was subdued at 3.22%, but previous revisions have been a mixed bag

EBITDA came in at ₹100.1 crore down 9.6% YoY compared to ₹110.7 crore reflecting operating margin pressure.

EBITDA margin improved to 11.2% vs. 9.7% last year, reflecting better cost management and higher profitability.

Shilpa Medicare said it has completed Phase 3 trials for SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets in 165 NAFLD patients in India.

A look at what stocks the Big-10 Mutual Fund Houses are buying and selling in January 2025

Here are some of the stocks that may see significant price movement today: Paytm, Bank of Baroda, Kalpataru Project, etc.

At 3.0%, the US consumer inflation is a full 100 bps above the Fed target of 2.0%, reducing further rate cut hopes

While food inflation is perceptibly lower in January 2025, there has been a rebound in core inflation